Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia
Venetoclax is a powerful new kind of oral medication. It enables leukemia cells to die by interfering with Bcl-2, a […]
molecules
Companion Diagnostics? For Cancer Care, We Need Better Ones
These biomarkers should link patients to optimal therapy (when such exists), and lead some to decline therapy that’s unlikely to
Companion Diagnostics? For Cancer Care, We Need Better Ones Read More »
Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
So far, the studies demonstrate that Lynparza has activity in cancer patients with and without inherited BRCA mutations.
A Chip against Cancer: Microfluidics Spots Circulating Tumor Cells
With an ordinary blood sample, a device can monitor cancerous cells for spread or resistance to treatment.
A Chip against Cancer: Microfluidics Spots Circulating Tumor Cells Read More »